Graziella A. Griffith
1 Université De Versailles St Quentin, U1179 INSERM
Montigny-sur-loing, France
Montigny-sur-loing, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Evaluating the Impact of Variable Phosphorothioate Content in Tricyclo-DNA Antisense Oligonucleotides in a Duchenne Muscular Dystrophy Mouse Model.
Journal: Nucleic acid therapeutics
Published: April 23, 2019
Initial results from the New Horizons exploration of 2014 MU69, a small Kuiper Belt object.
Journal: Science (New York, N.Y.)
Published: February 20, 2019
AAV-8 and AAV-9 Vectors Cooperate with Serum Proteins Differently Than AAV-1 and AAV-6.
Journal: Molecular therapy. Methods & clinical development
Published: June 01, 2018
Efficacy and Safety Profile of Tricyclo-DNA Antisense Oligonucleotides in Duchenne Muscular Dystrophy Mouse Model.
Journal: Molecular therapy. Nucleic acids
Published: May 22, 2017
Efficient SMN Rescue following Subcutaneous Tricyclo-DNA Antisense Oligonucleotide Treatment.
Journal: Molecular therapy. Nucleic acids
Published: January 31, 2017
Functional correction and cognitive improvement in dystrophic mice using splice-switching tricyclo-DNA oligomers
Journal: Medecine sciences : M/S
Published: April 10, 2015
Dystrophin rescue by trans-splicing: a strategy for DMD genotypes not eligible for exon skipping approaches.
Journal: Nucleic acids research
Published: July 18, 2013
Muscle function recovery in golden retriever muscular dystrophy after AAV1-U7 exon skipping.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: September 13, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026